SDWMA
ABBV icon

Schneider Downs Wealth Management Advisors’s AbbVie ABBV Stock Holding History

Schneider Downs Wealth Management Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630K Hold
2,505
– – 0.06% 95
2026
Q1 		$545K Sell
2,505
-6
-0.2% -$1.33K 0.06% 94
2025
Q4 		$574K Buy
2,511
+1,206
+92% +$275K 0.06% 91
2025
Q3 		$302K Buy
1,305
+12
+0.9% +$2.44K 0.04% 120
2025
Q2 		$240K Sell
1,293
-133
-9% -$24.7K 0.04% 131
2025
Q1 		$299K Sell
1,426
-68
-5% -$13.2K 0.05% 111
2024
Q4 		$265K Hold
1,494
– – 0.05% 117
2024
Q3 		$295K Sell
1,494
-39
-3% -$7.28K 0.06% 113
2024
Q2 		$263K Sell
1,533
-226
-13% -$37.4K 0.06% 112
2024
Q1 		$320K Buy
1,759
+201
+13% +$34.6K 0.07% 99
2023
Q4 		$241K Sell
1,558
-400
-20% -$58.3K 0.06% 102
2023
Q3 		$292K Hold
1,958
– – 0.07% 84
2023
Q2 		$264K Hold
1,958
– – 0.06% 93
2023
Q1 		$312K Hold
1,958
– – 0.06% 87
2022
Q4 		$316K Sell
1,958
-421
-18% -$64.6K 0.07% 86
2022
Q3 		$319K Sell
2,379
-569
-19% -$81.7K 0.09% 85
2022
Q2 		$452K Sell
2,948
-204
-6% -$31.2K 0.13% 76
2022
Q1 		$511K Buy
3,152
+19
+0.6% +$2.76K 0.13% 76
2021
Q4 		$424K Sell
3,133
-100
-3% -$11.8K 0.1% 91
2021
Q3 		$349K Buy
3,233
+190
+6% +$21.7K 0.09% 93
2021
Q2 		$343K Buy
3,043
+37
+1% +$4.17K 0.09% 90
2021
Q1 		$325K Buy
3,006
+581
+24% +$62.1K 0.08% 87
2020
Q4 		$260K Sell
2,425
-485
-17% -$46.6K 0.07% 74
2020
Q3 		$255K Buy
2,910
+14
+0.5% +$1.32K 0.09% 82
2020
Q2 		$284K Hold
2,896
– – 0.1% 67
2020
Q1 		$221K Buy
+2,896
New +$247K 0.08% 83

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Schneider Downs Wealth Management Advisors's ABBV Position: Q2 2026 in Review

Schneider Downs Wealth Management Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 2,505 shares worth $630K. The position accounts for 0.06% of the portfolio, ranked #95.

Schneider Downs Wealth Management Advisors first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Schneider Downs Wealth Management Advisors held 2,505 shares of AbbVie worth $630K as of Q2 2026.
  • Schneider Downs Wealth Management Advisors left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.06% of Schneider Downs Wealth Management Advisors's portfolio in Q2 2026, its #95 holding.
  • Schneider Downs Wealth Management Advisors first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Schneider Downs Wealth Management Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.